Cargando…
Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment opt...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323790/ https://www.ncbi.nlm.nih.gov/pubmed/35877237 http://dx.doi.org/10.3390/curroncol29070377 |